BIOMAT Database Logo BIOMAT Database Logo

Relationship of skeletal muscle fiber type to serum high density lipoprotein cholesterol and apolipoprotein A-I levels. 1991

H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
Department of Clinical Chemistry, Helsinki University Central Hospital, Finland.

We measured the percentage of slow-twitch (ST) muscle fibers in the lateral portion of the quadriceps femoris muscle in 41 healthy sedentary male controls, 35 active male joggers, and 26 male coronary heart disease (CHD) patients. We then compared these percentages with serum levels of total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (apo A-I) found in these 102 middle-aged men. The percentage of ST muscle fibers in all men correlated positively with serum HDL-C (r = 0.57, P less than 0.001) and with apo A-I (r = 0.60, P less than 0.001) and negatively with triglycerides (r = -0.43, P less than 0.001). The proportion of ST fibers in joggers (65%; 61-69%, 95% confidence interval) was higher (P less than 0.001) than in sedentary controls (48%; 44-52%) or in CHD patients (44%; 39-49%). Moreover, 89% of the joggers had a proportion of ST fibers higher than 50%, whilst in sedentary controls and in CHD patients these values were 46% and 38%, respectively. Positive correlations were found between the percentage of ST fibers and both HDL-C and apo A-I in controls (r = 0.33, P less than 0.05 and r = 0.34, P less than 0.05) and in joggers (r = 0.46, P less than 0.01, and r = 0.40, P less than 0.05), respectively. Negative correlations in controls (r = -0.34, P less than 0.05) and in CHD patients (r = -0.43, P less than 0.05) were also found between the percentage of ST fibers and serum TG.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007590 Jogging Running at a low rate of speed. It can be done as a means of conditioning or for general health and well being. Joggings
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I

Related Publications

H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels.
February 2006, Endocrine reviews,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
Relationship between non-high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease.
November 2020, Coronary artery disease,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
Decreased skeletal muscle capillary density is related to higher serum levels of low-density lipoprotein cholesterol and apolipoprotein B in men.
October 1999, Metabolism: clinical and experimental,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
Serum high density lipoprotein cholesterol, apolipoprotein A-I, A-II and B levels in Singapore ethnic groups.
November 1987, Atherosclerosis,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
The effect of nutritional supplements on serum high-density lipoprotein cholesterol and apolipoprotein A-I.
August 2014, American journal of cardiovascular drugs : drugs, devices, and other interventions,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
[Apolipoprotein A-I and high-density lipoprotein cholesterol in familial hyperlipoproteinemias].
June 1986, Vnitrni lekarstvi,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
Identification of Sequence Variation in the Apolipoprotein A2 Gene and Their Relationship with Serum High-Density Lipoprotein Cholesterol Levels.
January 2016, Iranian biomedical journal,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
December 2010, The Journal of clinical endocrinology and metabolism,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
August 1982, American journal of epidemiology,
H O Tikkanen, and M Härkönen, and H Näveri, and E Hämäläinen, and R Elovainio, and S Sarna, and M H Frick
High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I.
May 1992, Transgenic research,
Copied contents to your clipboard!